Aileron Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
- Nebius shares sink on CoreWeave's bond yield spike and insider sales
- IonQ prices $2 billion equity offering at $40 per share
- Rocket Lab delays Neutron rocket debut to 2027
- Bloom Energy stock falls as inflation data pressures markets
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
Aileron Therapeutics (ALRN) IPO Opens Lower
June 29, 2017 11:23 AM EDTToday's IPO for Aileron Therapeutics (NASDAQ: ALRN) opened for trading at $13.75 after pricing 3,750,000 shares of common stock at a public offering price of $15.00 per share.
BofA Merrill Lynch and Jefferies are acting as lead joint book-running managers and as representatives of the... More



